Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl H June

Showing results (81-90 of 460) with videos related to

Pageof 46
Sort By:
Frontiers in Immunology|November 13, 2018
Expanding the Therapeutic Window for CAR T Cell Therapy in Solid Tumors: The Knowns and Unknowns of CAR T Cell BiologyKeisuke Watanabe, Shunichiro Kuramitsu, Avery D Posey, et al.
Nature Reviews. Cancer|July 24, 2024
Enhancing cellular immunotherapies in cancer by engineering selective therapeutic resistanceNils Wellhausen, Joanne Baek, Saar I Gill, et al.
Nature Reviews. Drug Discovery|January 10, 2019
Delivery technologies for cancer immunotherapyRachel S Riley, Carl H June, Robert Langer, et al.
Expert Review of Anticancer Therapy|February 19, 2008
Immunotherapy opportunities in ovarian cancerChristina S Chu, Sarah H Kim, Carl H June, et al.
Oncoimmunology|July 29, 2016
Ovarian cancer chemokines may not be a significant barrier during whole tumor antigen dendritic-cell vaccine and adoptive T-cell immunotherapyEmese Zsiros, Denarda Dangaj, Carl H June, et al.
Seminars in Immunology|August 9, 2011
Clinical perspectives for regulatory T cells in transplantation toleranceKeli L Hippen, James L Riley, Carl H June, et al.
Seminars in Immunology|September 20, 2023
Beyond youth: Understanding CAR T cell fitness in the context of immunological agingJulia Han Noll, Bruce L Levine, Carl H June, et al.
Journal of Visualized Experiments : Jove|February 9, 2026
Efficient Production of Chimeric Antigen Receptor (CAR) T Cells with Transgenes Exceeding 10 kb Using Lentiviral VectorsPhilipp C Rommel, Nils W Engel, Bruce L Levine, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2018
Immunotherapy for Glioblastoma: Adoptive T-cell StrategiesBryan D Choi, Marcela V Maus, Carl H June, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2008
Cutting edge: Foxp3-mediated induction of pim 2 allows human T regulatory cells to preferentially expand in rapamycinSamik Basu, Tatiana Golovina, Tatiana Mikheeva, et al.
Pageof 46

Showing results (81-90 of 460) with videos related to

Sort By:
Pageof 46
Frontiers in Immunology|November 13, 2018
Expanding the Therapeutic Window for CAR T Cell Therapy in Solid Tumors: The Knowns and Unknowns of CAR T Cell BiologyKeisuke Watanabe, Shunichiro Kuramitsu, Avery D Posey, et al.
Nature Reviews. Cancer|July 24, 2024
Enhancing cellular immunotherapies in cancer by engineering selective therapeutic resistanceNils Wellhausen, Joanne Baek, Saar I Gill, et al.
Nature Reviews. Drug Discovery|January 10, 2019
Delivery technologies for cancer immunotherapyRachel S Riley, Carl H June, Robert Langer, et al.
Expert Review of Anticancer Therapy|February 19, 2008
Immunotherapy opportunities in ovarian cancerChristina S Chu, Sarah H Kim, Carl H June, et al.
Oncoimmunology|July 29, 2016
Ovarian cancer chemokines may not be a significant barrier during whole tumor antigen dendritic-cell vaccine and adoptive T-cell immunotherapyEmese Zsiros, Denarda Dangaj, Carl H June, et al.
Seminars in Immunology|August 9, 2011
Clinical perspectives for regulatory T cells in transplantation toleranceKeli L Hippen, James L Riley, Carl H June, et al.
Seminars in Immunology|September 20, 2023
Beyond youth: Understanding CAR T cell fitness in the context of immunological agingJulia Han Noll, Bruce L Levine, Carl H June, et al.
Journal of Visualized Experiments : Jove|February 9, 2026
Efficient Production of Chimeric Antigen Receptor (CAR) T Cells with Transgenes Exceeding 10 kb Using Lentiviral VectorsPhilipp C Rommel, Nils W Engel, Bruce L Levine, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2018
Immunotherapy for Glioblastoma: Adoptive T-cell StrategiesBryan D Choi, Marcela V Maus, Carl H June, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2008
Cutting edge: Foxp3-mediated induction of pim 2 allows human T regulatory cells to preferentially expand in rapamycinSamik Basu, Tatiana Golovina, Tatiana Mikheeva, et al.
Pageof 46